x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




Generic KRKA to receive damages in Nexium case

28-01-2014

Generic KRKA to receive damages in Nexium case

The UK High Court has decided to award Slovenian generic pharmaceutical company KRKA damages after a preliminary injunction enforced against the company by AstraZeneca was discharged.


AstraZeneca, KRKA, Nexium, Emozul, generic pharmaceuticals, UK High Court

WIPR

Payment types accepted